Cargando…
Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era
BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARs-CoV-2) has resulted in a global pandemic. Hydroxychloroquine±azithromycin have been widely used to treat coronavirus disease 2019 (COVID-19) despite a paucity of evidence regarding efficacy. The incidence of torsade de pointes rem...
Autores principales: | Saleh, Moussa, Gabriels, James, Chang, David, Fishbein, Joanna, Qiu, Michael, Mountantonakis, Stavros E., Epstein, Laurence M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7668332/ https://www.ncbi.nlm.nih.gov/pubmed/33003964 http://dx.doi.org/10.1161/CIRCEP.120.008937 |
Ejemplares similares
-
Atrial fibrillation is an independent predictor for in-hospital mortality in patients admitted with SARS-CoV-2 infection
por: Mountantonakis, Stavros E., et al.
Publicado: (2021) -
Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin
por: Gabriels, James, et al.
Publicado: (2020) -
Paroxetine‐induced QTc prolongation
por: Otsuka, Yuji
Publicado: (2017) -
Problems with Bazett QTc correction in paediatric screening of prolonged QTc interval
por: Andršová, Irena, et al.
Publicado: (2020) -
Out-of-Hospital Cardiac Arrest and Acute Coronary Syndrome Hospitalizations During the COVID-19 Surge
por: Mountantonakis, Stavros E., et al.
Publicado: (2020)